A Few Words About Us

A Symbiotic Relationship

In 2009, our physicians integrated to form a partnership so that we can deliver a state-of-the art comprehensive solution to prostate cancer. Our physicians have been in practice independently and some have served for over 15 years in the Valley. Many of our physicians have served as leaders in the community steering tumor boards, oncology committees, physician leadership councils, and some have served on the faculty at the University of Arizona Medical School in Tucson. We strive to practice and deliver the latest technological developments developed for prostate cancer as defined by the highest echelon of the standard of care. Many of our physicians have written many publications in peer-reviewed journals, given lectures to prostate cancer support groups, presented at national meetings, and are now actively involved as principal investigators in a variety of clinical trials to bring the latest developing treatments to the realm of clinical medicine. To list every accomplishment, honor, and publication of each of our physicians would be superficial. We believe that each patient should develop the trust of a physician when we initiate the physician-patient relationship face to face, not because of our curriculum vitae, but based on our expertise in the understanding and treatment of prostate cancer.

Our Physicians


Jonathan W. Agins, MD
Dr. Jonathan W. Agins completed his training in Urology at SUNY Brooklyn and at Memorial Sloan-Kettering Cancer Center, receiving an education by the world’s foremost scholars in all aspects of Urology. He serves as the Chairman of Arrowhead Hospital Physician Leadership Committee, Vice Chairman of Surgery at Arrowhead, Credentials Committee of Arrowhead, and a Consultant for the Arizona Medical Board.






Shawn D. Blick, MD
Dr. Shawn Blick graduated from Mount Sinai Medical School with honors and completed his Urology residency at Beth Isreal Medical Center in New York City.  He compled 6 months of oncology training at Memorial Sloan Kettering Cancer Center. He has extensive experience in cyroablation and robotic assisted laparoscopic prostatectomies for prostate cancer, and hand assisted laparoscopic nephrectomies for kidney cancer.  He is an Adjunctive Faculty Member at Midwestern University and has been given an award for his teaching skills.






Lynn W. Blunt, MD
Dr. Lynn W. Blunt, Jr. completed his residency in Urology at The McGraw Medical Center of Northwestern University.  He served as The Chairman for the Division of Urology at Mount Sinai Hospital in Chicago. He also served as the institution’s Physician Liaison to The Commission on Cancer for The American College of Surgeons, making Dr. Blunt a leading authority in Urologic Oncology.




Vi N. Hua, MD
Dr. Vi Hua attended The University of Texas, Southwestern Medical School and completed his Urology residency at The McGraw Medical Center of Northwestern University.  His area of expertise include laparoscopy and minimally invasive urology.  He has extensive experience in nephron sparing laparoscopic partial nephrectomies, laparoscopic renal cryoablation, and laparoscopic DaVinci robotic radical prostatectomies.




Torre H. Rhoades, MD
Dr. Torre Rhoades completed his urology training at the University of Cincinnati and Fellowship in Urologic Oncology at the Cleveland Clinic in Florida.  He is an expert with Robotics and Laparoscopy surgery.  He is able to offer Continent Diversions (NeoBladders) for patients requiring radical cystectomy for muscle invasive bladder cancer. His academic career was remarkable for publishing numerous articles in International Journals as well as delivering lectures. 




Rahul K. Thaly, MD
Dr. Rahul Thaly completed Urology residency at the University of Illinois at Chicago.  He went on to further training in Robotics/Laparoscopy and Minimally Invasive Surgery at The Ohio State University under the guidance of Dr. Vipul Patel, the foremost leader in Robotic and Minimally Invasive Surgery.  He has been involved in more than 400 robotic and laparoscopic surgeries. In addition to robotic surgery for prostate cancer, he also specializes in the treatment of kidney cancer with minimally invasive, kidney sparing alternative such as laparoscopic partial nephrectomy and radiofrequency ablation. 





Christopher Biggs, MD, PhD
Dr. Biggs attended the University of Arizona, where he received a Bachelors of Science in Molecular and Cellular biology.  He received his PhD at University of Southern California.  There he performed research on molecular genetics of cancer at the Norris Cancer Center.  Afterwards, he completed medical school at Stanford and residency at University of California, San Francisco.  He spent five years performing radiosurgery at Barrow Neurological Institute. He has been named Phoenix Top Doctor 2010 by Phoenix Magazine.






Terry Lee, MD
Dr. Lee graduated from the University of California, Los Angeles with a Bachelors degree in Mechanical Engineering.  He attended Tuft’s University Medical School and also received his Masters Degree at MIT in Nuclear Engineering.  As a graduate student, he explored new cancer treatment option using Boron Neutron Capture Therapy.  Dr. Lee trained at University of California, San Francisco in Radiation Oncology.  He spent 6 years at Banner Good Samaritan Hospital and Phoenix Children’s Hospital. He has been named Phoenix Top Doctor 2009 by Phoenix Magazine. 






Daniel Reed, DO
Dr. Reed completed his residency at University of Washington after receiving his medical degree from West Virginia School of Osteopathic Medicine.  Dr. Reed became the Seattle Prostate Institute/American Brachytherapy Society Prostate Fellowship Coordinator through 2005.  He recently authored the 2007 National Treatment Guideline of the American College of Radiology for Prostate Cancer Radiation Therapy.   He has been named Phoenix Top Doctor 2009 by Phoenix Magazine.





James Choi, MD
Dr. Choi attended Case Western Reserve University with a Bachelors Degree in Biochemistry.  He then attended Wright State University for medical school.  He completed his fellowship in medical oncology and hematology at the University of Arizona.  During his fellowship, he served as chief fellow, published several research articles, and presented his research at American Society of Hematology national meeting.  Dr. Choi’s clinical interest include treatment of advanced prostate, bladder, and kidney cancer. 















Our advantages

Bringing to the Market Services Patients Need

We have brought together some of the most advanced technology for surgical and radiation therapy for prostate cancer. We strive to provide therapies that optimize the least side effects, convalescence, and